The article discusses the growing use of GLP-1 drugs like semaglutide (Ozempic) and liraglutide (Saxenda), which were originally developed for diabetes but are now widely used for weight loss. These medications have changed societal perceptions of body image, particularly affecting women, by promoting extreme thinness. The article highlights concerns raised by the humanitarian organization Humanitarček, which received multiple requests for financial assistance in paying for these drugs. Some applicants claimed they were advised by doctors to seek help from humanitarian organizations. The piece explores the broader implications of this trend, including the economic burden on individuals who cannot afford these expensive treatments and the ethical questions surrounding their medical use beyond approved indications.
Bias read (Progressive): The article critiques the societal pressures driving the demand for weight-loss drugs and highlights systemic issues such as healthcare accessibility and the role of medical professionals in directing patients to charitable aid. It frames the issue through a lens of social inequality and ethical mis






